FFA
CGON icon

Farther Finance Advisors’s CG Oncology CGON Stock Holding History

Farther Finance Advisors’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06K Buy
29
+5
+21% +$327 ﹤0.01% 5161
2026
Q1 		$1.6K Buy
24
+14
+140% +$793 ﹤0.01% 4968
2025
Q4 		$415 Hold
10
– – ﹤0.01% 5087
2025
Q3 		$403 Buy
+10
New +$291 ﹤0.01% 4588

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Farther Finance Advisors's CGON Position: Q2 2026 in Review

Farther Finance Advisors increased its CG Oncology (CGON) stake by 21% in Q2 2026, buying an estimated $327 and bringing the position to 29 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #5161.

Farther Finance Advisors first reported a position in CGON in Q3 2025 and has held it in 4 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Farther Finance Advisors held 29 shares of CG Oncology worth $2.06K as of Q2 2026.
  • Farther Finance Advisors bought 5 CG Oncology shares in Q2 2026, an estimated $327.
  • CG Oncology made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5161 holding.
  • Farther Finance Advisors first reported a position in CG Oncology in Q3 2025 and has held it in 4 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.